LOUIS G LANGE

CIK 1238401 · EVP Cardiovascular Therapeutic · last filed 2026-03-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$839.9K

Companies

6

Total Filings

70

Lifetime Open-Market Net

-$20.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAMSW Director 10,360 $18.80 $194.8K -$2.09M 10 2026-03-12
BOLD Director 0 $1.41 $0 -$9.35M 19 2020-01-15
CymaBay Therapeutics, Inc. (CBAY) Delisted Director $32.48 $0 2 2015-06-30
ESPR Director 204,803 $3.15 $645.1K $199.0K 1 2013-07-01
GILD EVP Cardiovascular Therapeutic $125.59 $0 2 2009-05-08
CV THERAPEUTICS INC (CVTX) Delisted Chairman & CEO 490,432 -$9.54M 25 2009-04-17

Recent Filings · Page 4 of 7

70 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-01-08 CymaBay Therapeutics, Inc. (CBAY) Delisted Grant (A) $0 EDGAR
2014-01-15 Grant (A) $0
2014-01-08 Grant (A) $0
2013-12-27 Mixed $0
2013-11-01 Grant (A) $0
2013-07-01 ESPR Mixed +215,517 $199.0K EDGAR
2012-06-07 Grant (A) +10,000 $0
2011-06-01 Grant (A) +10,000 $0
2010-05-27 Grant (A) +10,000 $0
2009-09-24 Grant (A) +30,000 $0
Showing 3140 of 70
Page 4 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.